Yulia Melenevsky

Efficacy and Safety of Single-Agent Pertuzumab, a Human Epidermal Receptor Dimerization Inhibitor, in Patients with Non–Small Cell Lung Cancer

Roy S. Herbst, Angela M. Davies, Ronald B. Natale et al. · Clinical Cancer Research · 2007 · 98 citations

ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with ¹⁸F-FDG PET and Correlation with Genotype and GLUT4 Expression

Annick D. Van den Abbeele, Constantine Gatsonis, D.J. de Vries et al. · Journal of Nuclear Medicine · 2012 · 55 citations · Full text

ACR Appropriateness Criteria ® Imaging After Total Knee Arthroplasty

Mary G. Hochman, Yulia Melenevsky, Darlene Metter et al. · Journal of the American College of Radiology · 2017 · 42 citations · Full text

Medical Imaging, Musculoskeletal Imaging, Orthopaedics +7

On-Call Musculoskeletal Radiographs: Discrepancy Rates Between Radiology Residents and Musculoskeletal Radiologists

Justin W. Kung, Yulia Melenevsky, Mary G. Hochman et al. · American Journal of Roentgenology · 2013 · 24 citations

Imaging kinase target inhibition with SU11248 by FDG-PET in patients (pts) with imatinib-resistant gastrointestinal stromal tumors (I-R GIST)

A. Van Den Abbeele, Yulia Melenevsky, Daniel H. de Vries et al. · Journal of Clinical Oncology · 2005 · 23 citations

Engineering, Oncologic Imaging, Pathology +20